Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of neuronal nitric oxide synthase inhibitors for immunotherapy in melanoma patients

Use of neuronal nitric oxide synthase inhibitors for immunotherapy in melanoma patients

US Patent 11439632 · Granted Sep 13, 2022

Estimated economic value: $88,688,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fluorine substituted cyclohexene analogues of gamma-aminobutyric acid (GABA)2025
Process for the synthesis of (s) 3-amino-4-(difluoromethylenyl)cyclopent-1-ene-12025
Substituted fused pyrimidine compounds and uses thereof2025
Potent and selective human neuronal nitric oxide synthase inhibitors2025
Bacterial nitric oxide synthase inhibitors2025
APE/REF1 inhibitors for the treatment of cancer2024
Use of neuronal nitric oxide synthase inhibitors for immunotherapy in melanoma p2024
Use of neuronal nitric oxide synthase inhibitors for immunotherapy in melanoma p2024
3-amino-4-halocyclopentene carboxylic acids as inactivators of aminotransferases2024
Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical 2022
Inactivators of toxoplasma gondii ornithine aminotransferase for treating toxopl2021
Analogs of 3-amino-4-(propan-2-ylidene)cyclopentane-1-carboxylic acid and uses t2021